NasdaqGS:HSICHealthcare
Assessing Henry Schein (HSIC) Valuation After Earnings Beat And Reaffirmed Guidance
Earnings beat and guidance reaffirmation put Henry Schein (HSIC) in focus
Henry Schein (HSIC) is back on investors’ radar after first quarter 2026 adjusted earnings per share of $1.32 and net sales of $3.37b topped estimates, alongside reaffirmed full year sales and earnings guidance.
See our latest analysis for Henry Schein.
The reaffirmed guidance and stronger first quarter have been met with a 6.92% 1 month share price return and a 10.06% 1 year total shareholder return, suggesting...